Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Tate & Lyle pleased by volume momentum

(Sharecast News) - Tate&Lyle reported an increase in operating profits at the start of its 2025 fiscal year. That was despite the drag on the topline at its Food & Beverage solutions unit, although revenue growth at Sucralose was described as "good".

All in all, in a trading statement for the three months ending on 30 June the food ingredients maker said that group performance had met management's expectations.

It's encouraging to see volume momentum across the business, and we continue to expect volume growth to accelerate as the 2025 financial year progresses," the company's chief executive officer, Nick Hampton, said.

"Planning for the integration of Tate & Lyle and CP Kelco is progressing well with both organisations excited about the opportunity to deliver significantly greater value for customers and the growth potential of the combined business. We look forward to the future with confidence."

On 20 June the company had announced its intention to acquire CP Kelco, the pectin provider, for $1.8bn (£1.4bn).

Ahead of its AGM, the company also reiterated guidance for a dip in revenues on a constant currency basis while earnings before interest, taxes, depreciation and amortisation were seen rising by 4-7%.

As at 24 July, the company had repurchased 6.7m of its own shares at a cost of £42m as part of the £215m share buyback programme unveiled on 20 June.

Shares in Tate&Lyle were adding 0.86% to 648.50p as of 1510 BST.

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.